Delirium Reduction by Volatile Anesthesia in Cardiac Surgery (DELICATE)
Primary Purpose
Delirium
Status
Recruiting
Phase
Phase 4
Locations
Russian Federation
Study Type
Interventional
Intervention
Volatile agent
Propofol
Sponsored by
About this trial
This is an interventional prevention trial for Delirium focused on measuring delirium, Cardiac surgery, Cardiopulmonary bypass, Cognitive dysfunction
Eligibility Criteria
Inclusion Criteria:
- Males and females > 65 years
- Written informed consent
- Cardiac surgery with CPB
Exclusion Criteria:
- Emergency surgery
- Surgery on aorta
- Known allergy to components of anaesthesia
- Pregnancy
- Hemodynamically significant stenosis of carotid arteries
- Parkinson's disease
- Liver cirrhosis (Child B or C)
- Current enrollment into another RCT (in the last 30 days)
- Previous enrollment and randomization into the DELICATE trial
- Poor language comprehension
- Preoperative Medications: Anticholinergics (dimedrol, atropine, dramina), antidepressants, antiepileptics, antiparkinson drugs, chemotherapeutic agents
Sites / Locations
- M.F. Vladimirsky Moscow Regional Research and Clinical Institute (MONIKI)Recruiting
- Meshalkin Research Institute of Pathology of CirculationRecruiting
- Saint Petersburg State University HospitalRecruiting
- Tomsk National Research Medical Center of the Russian Academy of SciencesRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Volatile anesthesia group
TIVA group
Arm Description
Outcomes
Primary Outcome Measures
Postoperative delirium
Postoperative delirium detection will be managed with Confusion Assessment Method for the ICU (CAM-ICU)
Secondary Outcome Measures
Early postoperative cognitive dysfunction
We will use Montreal Cognitive Assessment (MoCA) to detect cognitive dysfunction
Delirium duration
number of days
Duration of ICU stay
number of days
Duration of hospital stay
number of days
30-day all-cause mortality
yes/no
One-year all-cause mortality
yes/no
Myocardial infarction (MI)
yes/no
Stroke
Stroke will be diagnosed by neurologist (yes/no)
Seizures
Presence of Seizures (yes/no)
Incidence of acute kidney injury (AKI)
According to KDIGO criteria
Renal replacement therapy
We will collect data about need of renal replacement therapy (yes/no)
Infectious complications
We will collect data about infectious complications: wound infection, mediastinitis, pneumonia, positive blood culture
Pain assessment with Behavioral Pain Scale (BPS)
The BPS is an observational pain scale. It has been validated for use in deeply sedated, mechanically ventilated patients. The BPS contains 3 subscales: facial expression, upper limb movements, and compliance with mechanical ventilation. Each subscale is scored from 1 (no response) to 4 (full response). Therefore, BPS scores range from 3 (no pain) to 12 (maximal pain). A BPS score of 6 or higher is considered to reflect unacceptable pain.
Pain assessment with Numerical Rating Scale (NRS)
A NRS involves asking the patient to rate his or her pain from 0 to 10 (11 point scale) or from 0 to 100 (101 point scale) with the understanding that 0 is equal to no pain and 10 or 100 is equal to worst possible pain.
Full Information
NCT ID
NCT03729011
First Posted
October 3, 2018
Last Updated
August 30, 2022
Sponsor
Meshalkin Research Institute of Pathology of Circulation
1. Study Identification
Unique Protocol Identification Number
NCT03729011
Brief Title
Delirium Reduction by Volatile Anesthesia in Cardiac Surgery
Acronym
DELICATE
Official Title
Delirium Reduction by Volatile Anesthesia in Cardiac Surgery: Prospective, Randomized, Single-blinded Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 9, 2019 (Actual)
Primary Completion Date
December 29, 2022 (Anticipated)
Study Completion Date
January 29, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Meshalkin Research Institute of Pathology of Circulation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Parallel group, prospective, randomized, controlled, single-blinded trial. The aim of our study is to test the hypothesis that volatile anesthesia would reduce the incidence of early postoperative delirium in patients undergoing cardiac surgery with CPB as compared to TIVA.
Detailed Description
Delirium is a common neurologic complication after cardiac surgery. Up to 52% of postoperative cardiac surgery patients have delirium. The occurrence of postoperative delirium is associated with worse outcomes, including prolonged length of stay in the ICU and hospital, increased morbidity and mortality, compromised long-term cognitive function and physical ability, and elevated medical care costs. Morbidity of postoperative cognitive dysfunction and delirium mostly common in patients with age more than 60 years.
Several factors including cerebral anoxia, embolism, excessive excitatory neurotransmitter release, systemic inflammatory response, electrolyte and metabolic disorders and hemodynamic changes have been demonstrated to contribute to postoperative neurological dysfunction and delirium.
Previous studies have shown that inhalation anaesthesia and total intravenous anaesthesia (TIVA) may produce different degrees of cerebral protection in these patients. Effects of this two types of anaesthesia in cardiac surgery with CPB remain controversial and much debated.
Inhalation agents depress glucose metabolism, decrease cerebral metabolic rate and oxygen consumption. They also partially uncouple the reactivity of cerebral blood flow to CO2. The changes in cerebral blood flow (CBF) depend on the changes in cerebral metabolism and on direct vasodilatory effects. Cerebral autoregulation is dose-dependently altered. Volatile anaesthetics have been shown to initiate early ischemic preconditioning in neurons, but models of focal brain ischemia suggest it can take 24 h for preconditioning to develop fully.
Propofol is a well-known potentiator of GABAA receptors, it reduces cerebrovascular resistance, CBF and cerebral oxygen delivery during cardiopulmonary bypass. A neuroprotective effect of propofol has been shown to be present in many in vitro and in vivo established experimental models of mild/moderate acute cerebral ischemia.
In recent meta-analysis of 13 randomized controlled studies Chen et al compared the neuroprotective effects of inhalational anesthesia and those of total intravenous anesthesia (TIVA) in cardiac surgery with cardiopulmonary bypass. They have shown that anesthesia with volatile agents appeared to provide better cerebral protection than TIVA. As this meta-analysis had several limitations (small sample size of included studies, high heterogenity, etc.), further studies with larger clinically relevant sample-sizes are needed to demonstrate which anesthetics are more beneficial in terms of brain protection in cardiac surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium
Keywords
delirium, Cardiac surgery, Cardiopulmonary bypass, Cognitive dysfunction
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomly allocated to receive either inhalation anaesthesia or TIVA. Permuted-block randomization will be used to allocate subjects to one of the study groups. Sequentially numbered sealed opaque envelopes will contain the treatment code, to be opened in the morning of surgery. Patients will be unaware of group assignment. All the statistical analyses will be performed by the biostatistician not involved in treatment allocation.
Masking
Participant
Allocation
Randomized
Enrollment
672 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Volatile anesthesia group
Arm Type
Active Comparator
Arm Title
TIVA group
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Volatile agent
Other Intervention Name(s)
Sevoflurane, Desflurane, Isoflurane
Intervention Description
Patients will receive volatile agent to provide general anaesthesia, including CPB period. Volatile agents will be administered from anesthesia induction to the end of surgery. Concentration (MAC) of volatile agent will be selected by anaesthesiologist according to clinical situation and patient features.
Intervention Type
Drug
Intervention Name(s)
Propofol
Intervention Description
Patients will receive propofol and no volatile agent. Propofol will be used for induction and maintenance of anesthesia.
Primary Outcome Measure Information:
Title
Postoperative delirium
Description
Postoperative delirium detection will be managed with Confusion Assessment Method for the ICU (CAM-ICU)
Time Frame
5 days after surgery
Secondary Outcome Measure Information:
Title
Early postoperative cognitive dysfunction
Description
We will use Montreal Cognitive Assessment (MoCA) to detect cognitive dysfunction
Time Frame
7 days after surgery
Title
Delirium duration
Description
number of days
Time Frame
10 days after surgery
Title
Duration of ICU stay
Description
number of days
Time Frame
30 days
Title
Duration of hospital stay
Description
number of days
Time Frame
60 days
Title
30-day all-cause mortality
Description
yes/no
Time Frame
30 days
Title
One-year all-cause mortality
Description
yes/no
Time Frame
1 year
Title
Myocardial infarction (MI)
Description
yes/no
Time Frame
30 days
Title
Stroke
Description
Stroke will be diagnosed by neurologist (yes/no)
Time Frame
30 days
Title
Seizures
Description
Presence of Seizures (yes/no)
Time Frame
30 days
Title
Incidence of acute kidney injury (AKI)
Description
According to KDIGO criteria
Time Frame
30 days
Title
Renal replacement therapy
Description
We will collect data about need of renal replacement therapy (yes/no)
Time Frame
30 days
Title
Infectious complications
Description
We will collect data about infectious complications: wound infection, mediastinitis, pneumonia, positive blood culture
Time Frame
30 days
Title
Pain assessment with Behavioral Pain Scale (BPS)
Description
The BPS is an observational pain scale. It has been validated for use in deeply sedated, mechanically ventilated patients. The BPS contains 3 subscales: facial expression, upper limb movements, and compliance with mechanical ventilation. Each subscale is scored from 1 (no response) to 4 (full response). Therefore, BPS scores range from 3 (no pain) to 12 (maximal pain). A BPS score of 6 or higher is considered to reflect unacceptable pain.
Time Frame
5 days after surgery
Title
Pain assessment with Numerical Rating Scale (NRS)
Description
A NRS involves asking the patient to rate his or her pain from 0 to 10 (11 point scale) or from 0 to 100 (101 point scale) with the understanding that 0 is equal to no pain and 10 or 100 is equal to worst possible pain.
Time Frame
5 days after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Males and females > 65 years
Written informed consent
Cardiac surgery with CPB
Exclusion Criteria:
Emergency surgery
Surgery on aorta
Known allergy to components of anaesthesia
Pregnancy
Hemodynamically significant stenosis of carotid arteries
Parkinson's disease
Liver cirrhosis (Child B or C)
Current enrollment into another RCT (in the last 30 days)
Previous enrollment and randomization into the DELICATE trial
Poor language comprehension
Preoperative Medications: Anticholinergics (dimedrol, atropine, dramina), antidepressants, antiepileptics, antiparkinson drugs, chemotherapeutic agents
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Vladimir Lomivorotov, PHD
Phone
347 60 54
Ext
383
Email
vvlom@mail.ru
First Name & Middle Initial & Last Name or Official Title & Degree
Gleb Moroz, PHD
Phone
347 60 54
Ext
383
Email
Glebmorozz@gmail.com
Facility Information:
Facility Name
M.F. Vladimirsky Moscow Regional Research and Clinical Institute (MONIKI)
City
Moscow
Country
Russian Federation
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Valery Lichvancev
Email
lik0704@gmail.com
First Name & Middle Initial & Last Name & Degree
Galina Titova
Email
galinatitova@mail.ru
Facility Name
Meshalkin Research Institute of Pathology of Circulation
City
Novosibirsk
ZIP/Postal Code
630055
Country
Russian Federation
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vladimir Lomivorotov
Phone
3833476058
Email
v.lomivorotov@gmail.com
Facility Name
Saint Petersburg State University Hospital
City
Saint Petersburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sergey Efremov, PHD
Email
efremovsergm@gmail.com
Facility Name
Tomsk National Research Medical Center of the Russian Academy of Sciences
City
Tomsk
Country
Russian Federation
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nikolay Kamenshikov
Email
nikolajkamenof@mail.ru
12. IPD Sharing Statement
Citations:
PubMed Identifier
24514034
Citation
Brown CH. Delirium in the cardiac surgical ICU. Curr Opin Anaesthesiol. 2014 Apr;27(2):117-22. doi: 10.1097/ACO.0000000000000061.
Results Reference
background
PubMed Identifier
22200370
Citation
Martin BJ, Buth KJ, Arora RC, Baskett RJ. Delirium: a cause for concern beyond the immediate postoperative period. Ann Thorac Surg. 2012 Apr;93(4):1114-20. doi: 10.1016/j.athoracsur.2011.09.011. Epub 2011 Dec 24.
Results Reference
background
PubMed Identifier
20373345
Citation
Gottesman RF, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, Selnes OA, McKhann GM. Delirium after coronary artery bypass graft surgery and late mortality. Ann Neurol. 2010 Mar;67(3):338-44. doi: 10.1002/ana.21899.
Results Reference
background
PubMed Identifier
20345866
Citation
Rudolph JL, Inouye SK, Jones RN, Yang FM, Fong TG, Levkoff SE, Marcantonio ER. Delirium: an independent predictor of functional decline after cardiac surgery. J Am Geriatr Soc. 2010 Apr;58(4):643-9. doi: 10.1111/j.1532-5415.2010.02762.x. Epub 2010 Mar 22.
Results Reference
background
PubMed Identifier
11161124
Citation
Franco K, Litaker D, Locala J, Bronson D. The cost of delirium in the surgical patient. Psychosomatics. 2001 Jan-Feb;42(1):68-73. doi: 10.1176/appi.psy.42.1.68.
Results Reference
background
PubMed Identifier
19745202
Citation
Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009 Dec 1;180(11):1092-7. doi: 10.1164/rccm.200904-0537OC. Epub 2009 Sep 10.
Results Reference
background
PubMed Identifier
18577850
Citation
Bickel H, Gradinger R, Kochs E, Forstl H. High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study. Dement Geriatr Cogn Disord. 2008;26(1):26-31. doi: 10.1159/000140804. Epub 2008 Jun 24.
Results Reference
background
PubMed Identifier
26459347
Citation
Li YW, Li HJ, Li HJ, Feng Y, Yu Y, Guo XY, Li Y, Zhao BJ, Hu XY, Zuo MZ, Zhang HY, Wang MR, Ji P, Yan XY, Wu YF, Wang DX. Effects of two different anesthesia-analgesia methods on incidence of postoperative delirium in elderly patients undergoing major thoracic and abdominal surgery: study rationale and protocol for a multicenter randomized controlled trial. BMC Anesthesiol. 2015 Oct 13;15:144. doi: 10.1186/s12871-015-0118-5.
Results Reference
background
PubMed Identifier
29132782
Citation
Nguyen Q, Uminski K, Hiebert BM, Tangri N, Arora RC. Midterm outcomes after postoperative delirium on cognition and mood in patients after cardiac surgery. J Thorac Cardiovasc Surg. 2018 Feb;155(2):660-667.e2. doi: 10.1016/j.jtcvs.2017.09.131. Epub 2017 Oct 20.
Results Reference
background
PubMed Identifier
20309566
Citation
Cerejeira J, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB. The neuroinflammatory hypothesis of delirium. Acta Neuropathol. 2010 Jun;119(6):737-54. doi: 10.1007/s00401-010-0674-1. Epub 2010 Mar 24.
Results Reference
background
PubMed Identifier
20833941
Citation
Caplan JP, Chang G. Refeeding syndrome as an iatrogenic cause of delirium: a retrospective pilot study. Psychosomatics. 2010 Sep-Oct;51(5):419-24. doi: 10.1176/appi.psy.51.5.419.
Results Reference
background
PubMed Identifier
21168339
Citation
Siepe M, Pfeiffer T, Gieringer A, Zemann S, Benk C, Schlensak C, Beyersdorf F. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg. 2011 Jul;40(1):200-7. doi: 10.1016/j.ejcts.2010.11.024. Epub 2010 Dec 18.
Results Reference
background
PubMed Identifier
18693233
Citation
Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):764-72. doi: 10.1093/gerona/63.7.764.
Results Reference
background
PubMed Identifier
9776494
Citation
Wimmer-Greinecker G, Matheis G, Brieden M, Dietrich M, Oremek G, Westphal K, Winkelmann BR, Moritz A. Neuropsychological changes after cardiopulmonary bypass for coronary artery bypass grafting. Thorac Cardiovasc Surg. 1998 Aug;46(4):207-12. doi: 10.1055/s-2007-1010226.
Results Reference
background
PubMed Identifier
29025825
Citation
Chen F, Duan G, Wu Z, Zuo Z, Li H. Comparison of the cerebroprotective effect of inhalation anaesthesia and total intravenous anaesthesia in patients undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis. BMJ Open. 2017 Oct 11;7(10):e014629. doi: 10.1136/bmjopen-2016-014629.
Results Reference
background
PubMed Identifier
19234823
Citation
Morimoto Y, Yoshimura M, Utada K, Setoyama K, Matsumoto M, Sakabe T. Prediction of postoperative delirium after abdominal surgery in the elderly. J Anesth. 2009;23(1):51-6. doi: 10.1007/s00540-008-0688-1. Epub 2009 Feb 22.
Results Reference
background
PubMed Identifier
10582614
Citation
Sagara Y, Hendler S, Khoh-Reiter S, Gillenwater G, Carlo D, Schubert D, Chang J. Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem. 1999 Dec;73(6):2524-30. doi: 10.1046/j.1471-4159.1999.0732524.x.
Results Reference
background
PubMed Identifier
21196338
Citation
Wang H, Lu S, Yu Q, Liang W, Gao H, Li P, Gan Y, Chen J, Gao Y. Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effects. Front Biosci (Elite Ed). 2011 Jan 1;3(2):604-15. doi: 10.2741/e273.
Results Reference
background
PubMed Identifier
19672176
Citation
McAuliffe JJ, Loepke AW, Miles L, Joseph B, Hughes E, Vorhees CV. Desflurane, isoflurane, and sevoflurane provide limited neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm. Anesthesiology. 2009 Sep;111(3):533-46. doi: 10.1097/ALN.0b013e3181b060d3.
Results Reference
background
PubMed Identifier
24669972
Citation
Bilotta F, Stazi E, Zlotnik A, Gruenbaum SE, Rosa G. Neuroprotective effects of intravenous anesthetics: a new critical perspective. Curr Pharm Des. 2014;20(34):5469-75. doi: 10.2174/1381612820666140325110113.
Results Reference
background
PubMed Identifier
9202922
Citation
Young Y, Menon DK, Tisavipat N, Matta BF, Jones JG. Propofol neuroprotection in a rat model of ischaemia reperfusion injury. Eur J Anaesthesiol. 1997 May;14(3):320-6. doi: 10.1046/j.1365-2346.1997.00130.x.
Results Reference
background
PubMed Identifier
11954772
Citation
Ergun R, Akdemir G, Sen S, Tasci A, Ergungor F. Neuroprotective effects of propofol following global cerebral ischemia in rats. Neurosurg Rev. 2002 Mar;25(1-2):95-8. doi: 10.1007/s101430100171.
Results Reference
background
PubMed Identifier
1843831
Citation
Van Aken H, Van Hemelrijck J. Influence of anesthesia on cerebral blood flow and cerebral metabolism: an overview. Agressologie. 1991;32(6-7):303-6.
Results Reference
background
PubMed Identifier
28481752
Citation
Lingehall HC, Smulter NS, Lindahl E, Lindkvist M, Engstrom KG, Gustafson YG, Olofsson B. Preoperative Cognitive Performance and Postoperative Delirium Are Independently Associated With Future Dementia in Older People Who Have Undergone Cardiac Surgery: A Longitudinal Cohort Study. Crit Care Med. 2017 Aug;45(8):1295-1303. doi: 10.1097/CCM.0000000000002483.
Results Reference
background
Learn more about this trial
Delirium Reduction by Volatile Anesthesia in Cardiac Surgery
We'll reach out to this number within 24 hrs